Neuravi (Johnson & Johnson)
Neuravi (Johnson & Johnson) appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $2M, computed as the sum of (share × market size) across every appearance.
Its strongest position is Thrombectomy Devices Market at 0.1% share in a market growing at 6.5% CAGR. Average share across all tracked markets is 0.1%, indicating a diversified participant footprint.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Neuravi (Johnson & Johnson) against the peers it actually overlaps with in those segments.
Market positions
Avg share 0.1% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| Thrombectomy Devices Market | $1.9B | 0.1% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Neuravi (Johnson & Johnson)
Peers that show up alongside Neuravi (Johnson & Johnson) in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.